Page 50 - Study Team News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article NEW YORK, March 9, 2021 /PRNewswire/ -- Patients previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may produce levels of antibodies against COVID-19 after a one dose of the Pfizer Inc./BioNTech SE messenger RNA (mRNA) vaccine that are equal to or higher than people not previously infected have after two doses, a new study finds. Presented virtually March 9 at the Conference for Retroviruses and Opportunistic Infections (CROI), the results of the small, exploratory study also suggest that the immune responses in most pa...

CHAPEL HILL, N.C. - New research from the University of North Carolina at Chapel Hill suggests that people who have had COVID-19 may need only one shot...

Seropositive individuals show similar antibody levels to a second mRNA vaccine dose Seropositive individuals —people who received antibodies after COVID-19 infection — may be able to safely delay their second mRNA vaccine dose after all, according to the results of a new study. Increasing immunity is necessary for preventing the spread of SARS-CoV-2. The United States currently leads the world with over 28 million cases and recently reached a sobering milestone of over 500,000 deaths. The Centers for Disease Control and Prevention (CDC) suggests people who show prior immunity to the virus...

 E-Mail The tuberculosis (TB) vaccine Bacillus Calmette-Guerin (BCG) could protect newborns against a variety of common infections, such as upper respiratory tract infections, chest infections and diarrhoea, according to a new study in The Lancet Infectious Diseases. The research is the first of its kind to rigorously investigate the full range of illnesses BCG could protect infants against. It suggests that vaccinating all babies on the day of birth with BCG could reduce neonatal infections and death in areas with high infectious disease rates, potentially saving thousands of lives a year....

By Nancy Nethercott Walking through the noisy streets of New York, I noticed people talking loudly on the phone or with headphones on listening to music, some loud enough for me to join in on what they were hearing. I felt accosted by the noise overload from the sound of traffic and construction, and by the visual overload of advertising. Needing a break from the sounds and sights of distracted life, I ducked into a church whose doors were open and invited me in with a sign that read: “Enter freely; enter quietly.” I stepped into another world—another culture—where my attention was ca...